TGEN trades 43.4% below Wall Street's consensus target of $7.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes TGEN achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 30, 2026, Tecogen Inc. (TGEN) has a Wall Street consensus price target of $7.50, based on estimates from 4 covering analysts. With the stock currently trading at $5.23, this represents a potential upside of +43.4%. The company has a market capitalization of $156M.
Analyst price targets range from a low of $7.50 to a high of $7.50, representing a 0% spread in expectations. The median target of $7.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, TGEN trades at a trailing P/E of -17.4x. Analysts expect EPS to grow +31.9% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CDTXCidara Therapeutics, Inc. | $7.0B | $221.38 | $177.88 | -19.6% | Buy | — | 11 |
PESIPerma-Fix Environmental Services, Inc. | $244M | $13.13 | $18.00 | +37.1% | Hold | — | 1 |
AMTXAemetis, Inc. | $115M | $1.69 | $1.75 | +3.6% | Buy | — | 7 |
CLNEClean Energy Fuels Corp. | $418M | $1.90 | $3.50 | +84.2% | Buy | — | 22 |
GNRCGenerac Holdings Inc. | $16.7B | $283.81 | $291.50 | +2.7% | Buy | 31.8x | 39 |
FCELFuelCell Energy, Inc. | $1.6B | $29.80 | $21.00 | -29.5% | Hold | — | 20 |
BLDPBallard Power Systems Inc. | $1.1B | $3.73 | $3.60 | -3.5% | Hold | — | 26 |
PLUGPlug Power Inc. | $3.0B | $2.59 | $1.85 | -28.6% | Buy | — | 38 |
AESThe AES Corporation | $10.4B | $14.63 | $18.33 | +25.3% | Hold | 6.3x | 21 |
NINiSource Inc. | $23.1B | $48.15 | $50.75 | +5.4% | Buy | 23.4x | 22 |
Quick answers to the most common questions about buying TGEN stock.
The consensus Wall Street price target for TGEN is $7.5, representing 43.4% upside from the current price of $5.23. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
TGEN has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $7.5 implies 43.4% upside from current levels.
TGEN's current price is $5.23 with a consensus target of $7.5 (43.4% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $7.5 for TGEN, while the most conservative target is $7.5. The consensus of $7.5 represents the median expectation. These targets typically reflect 12-month expectations.
TGEN is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month TGEN stock forecast based on 4 Wall Street analysts shows a consensus price target of $7.5, with estimates ranging from $7.5 (bear case) to $7.5 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on TGEN, with a "Buy" consensus rating and $7.5 price target (43.4% upside). 4 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
TGEN analyst price targets range from $7.5 to $7.5, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $7.5 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.